Search PubMed⌕ Search

Biomedical subjects

J Waller

Publications and source records attributed to J Waller.

At least 73 records · Page 4Linked to original sources
PubMed1983

[Gel fractionation of immunoglobulins in the detection of specific antitoxoplasma IgM. Evaluation of a 1-year study].

Toxoplasmosis seroconversion is diagnosed on the presence of fluorescent antibodies. IgG level kinetics and presence of IgM at the Remington test are usually the points taken in consideration. But the Remington test can be false positive, or inadequate. The authors report their experience of gel filtration of sera in toxoplasmosis, and discuss the help that this method can be establishing diagnosis in the case of a positive Remington test.

Chemical Fractionation↗
PubMed1980

Effect of sampling intervals and digesta markers on abomasal flow determinations.

Four sampling schedules and three digesta markers were investigated with abomasally-cannulated steers. Nonammonia nitrogen flow through the abomasum was used as the criterion for comparison. A single diet, consisting of ground corn cobs and cane molasses and supplemented with soybean meal to 11.5% crude protein, was used. Each steer was fed hourly to maintain a constant digesta flow. Digesta markers used were: polyethylene glycol (PEG) and chromic oxide (Cr2O3), as external markers for the liquid fraction and the particulate fraction, respectively; and indigestible neutral detergent fiber (INDF) and indigestible acid detergent fiber (IADF), as internal markers for the particulate fraction. Treatments were sampling intervals of 24 hr, 48 hr, 48 hr (sampled twice) and 72 hours. Sampling interval did not alter digesta flow through the abomasum. Extending sampling intervals beyond 24 hr or taking more than one sample per day did not appear advantageous. IADF and Cr2O3 appear to be suitable markers for the particulate fraction. However, IADF is an integral part of the particulate fraction and meets the criteria of an ideal marker.

Abomasum↗
PubMed1977

[Low molecule and middle molecule metabolites with haemodynamic activity in the ultrafiltrate from uraemic patients (author's transl)].

Substances causing blood pressure changes and myocardial damage in rats were first detected in the ultrafiltrate obtained from patients on long-term haemodialysis by means of size separation, high-voltage electrophoresis and thin-layer chromatography. Of the 100 to 140 fractions produced by Sephadex G 15 chromatography at least 3 raised the blood pressure when administered in doses of 2 to 10 mg/0.1 to 0.2 ml 0.9% NaCl, that is the high molecular fraction 18 to 23 and the low molecular fractions 71 to 72 and 73 to 74. The fractions 96 to 98 and 97 to 106 showed high toxicity. Less than 1 mg/0.1 to 0.2 ccm 0.9% NaCl produced cardiac arrest. The fractions 35 to 55, which originate from the middle molecules and are retained in regularly uraemia, contain substances which caused a reduction in blood pressure at low dosage and cardiotoxic effects at a dosage of more than 10 mg. Thin-layer chromatography indicates that the substances most probably consist of peptides whose structure contains the amino acids leucine, isoleucine, valine, glutamic acid, aspartic acid, alanine and cystine.

Humans↗
PubMed1976

[Hemofiltration in the treatment of generalized edema].

9 fluid overloaded patients, 8 of them with congestive heart failure and 1 patient with acute renal failure, were treated by ultrafiltration without hemodialysis. Using Gambro-major- and Rhone-Poulenc-6-dialysers the patients were deprived of 6,907.14+/-3,586.13 ml or 652.83 ml/h of extracellular fluid, on an average. During the withdrawal of fluid the plasma volume and central venous pressure decreased, whereas the cardiac output slightly increased. After the ultrafiltration, which did not show any undesirable side effects, the patients could be held in a compensative state by conservative therapy (digitalis and diuretics).

Aged↗
PubMed1976

Hemodynamic effects of nitroprusside infusion during coronary artery operation in man.

The hemodynamic response to vasodilator therapy with sodium nitroprusside has been assessed in 33 patients with severe coronary artery disease (CAD) during coronary artery operation. The patients were divided into three groups; Group 1 included seven patients with CAD and normal left ventricular filling pressure (LVFP less than 12 mm Hg); Group 2 included 18 patients with CAD and chronic left ventricular (LV) dysfunction (LVFP greater than 12 mm Hg) and Group 3 included eight patients with CAD and acute LV dysfunction (LVFP greater than 12 mm Hg) associated with an intraoperative hypertensive episode. Nitroprusside was administered intraoperatively at an initial infusion rate of 10-15 mcg/min and the rate was gradually increased thereafter until the criteria for effective therapy were satisfied. The effective dose ranged from 10-120 mcg/min with an average of 52 +/- 4 (SEM) mcg/min. In all three groups, pulmonary and systemic arterial pressure, right and left ventricular filling pressure, and pulmonary and systemic vascular resistance decreased significantly with nitroprusside infusion. Heart rate increased significantly in Group 1 and remained unchanged in Group 2 and 3. Heart rate X systolic arterial pressure decreased significantly in Group 1 and 3 and did not change in Group 2. Stroke index increased significantly in both groups of patients with elevated control LVFP (Group 2 and 3) and remained unchanged in patients with normal left ventricular function (Group 1). Left ventricular stroke work index decreased in Group 1, increased in Group 2, and remained unchanged in Group 3. Right ventricular stroke work index decreased significantly in all groups. These findings suggest that judicious intraoperative administration of sodium nitroprusside improves left ventricular function in patients with acute or chronic elevation of LVFP and LV dysfunction associated with severe CAD. Furthermore, nitroprusside is an effective drug for control of intraoperative hypertensive episodes in such patients.

Adult↗